Plus Therapeutics (PSTV) Exchange Rate Effect (2013 - 2019)
Plus Therapeutics (PSTV) reported Exchange Rate Effect of -$4000.0 for Q1 2019, down 110.26% year-over-year from $39000.0 in Q1 2018, and down 115.38% quarter-over-quarter from $26000.0 in Q4 2018.
Plus Therapeutics (PSTV) Exchange Rate Effect (2013 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has 7 years of Exchange Rate Effect data on file, last reported at -$4000.0 in Q1 2019.
- Exchange Rate Effect for Q1 2019 came in at -$4000.0, down 110.26% year-over-year; the trailing twelve-month figure through Dec 2019 was -$4000.0 (down 125.0% YoY), and the FY2019 annual result was -$4000.0, down 125.0% from the prior year.
- Exchange Rate Effect eased to -$4000.0 in Q1 2019 per PSTV's latest filing, from $26000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $85000.0 in Q1 2016 and troughed at -$58000.0 in Q4 2016.
- A 5-year average of $7000.0 and a median of $1000.0 in 2016 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2015 and 2016: Exchange Rate Effect tumbled 3000.0% in 2015, then jumped 466.67% in 2016.
- A 5-year view of Exchange Rate Effect shows it stood at $14000.0 in 2015, then tumbled by 514.29% to -$58000.0 in 2016, then soared by 96.55% to -$2000.0 in 2017, then jumped by 1400.0% to $26000.0 in 2018, then slumped by 115.38% to -$4000.0 in 2019.
- Business Quant data shows PSTV's Exchange Rate Effect at -$4000.0 in Q1 2019, $26000.0 in Q4 2018, and -$22000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 8.68 Mn |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -4,000.00 |
| Mar 31, 2019 | -4,000.00 |
| Dec 31, 2018 | 26,000.00 |
| Dec 31, 2018 | 26,000.00 |
| Sep 30, 2018 | -22,000.00 |
| Sep 30, 2018 | -22,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Mar 31, 2018 | 39,000.00 |
| Mar 31, 2018 | 39,000.00 |
| Sep 30, 2017 | -2,000.00 |
| Sep 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Dec 31, 2016 | -58,000.00 |
| Dec 31, 2016 | -58,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |